This article delves into the transformative landscape of personalized medicine by 2026, specifically examining genetic therapies and their anticipated 18-month impact on US healthcare expenditures. We explore technological advancements, accessibility challenges, and economic models shaping this critical sector.

AI is set to transform U.S. healthcare diagnostics, promising a 20% accuracy boost by 2027. This post delves into the technologies, benefits, challenges, and ethical considerations of this revolutionary shift.